Rare diseases
Investigational molecules
Locations
Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
FranceA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
FranceStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
FranceComparing Abobotulinumtoxin A and Onabotulinumtoxin A for Adults with Upper Limb Spasticity
FranceFranceA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
FranceA Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is
FranceLong-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension
FranceA Study of ALXN1920 Compared to Placebo in Adults with Primary Membranous Nephropathy at High Risk for Disease Progression
FranceA study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
FranceA Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease
FranceStudy of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
